A new artificial intelligence test can now reveal precisely which men with prostate cancer will benefit most from abiraterone, a drug that can halve the risk of death. This “gamechanger” …
© Copyright by SYDNEY TV NEWS (A Digital Media Brand owned by AMAZON MEDIA LLC).